As of 2024-12-12, the Relative Valuation of StageZero Life Sciences Ltd (SZLS.TO) is (0.00) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 CAD, the upside of StageZero Life Sciences Ltd based on Relative Valuation is -105.3%.
The range of the Relative Valuation is (0.00) - (0.01) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 0.3x | 0.1x |
| Forward P/E multiples | 0.1x - 0.3x | 0.1x |
| Fair Price | (0.00) - (0.01) | (0.00) |
| Upside | -104.3% - -115.9% | -105.3% |
| Date | P/E |